Beijing University of Chinese Medicine, Beijing, 100105, China; Chenguang Biological Technology Group Co, Ltd, Handan, 057250, China.
Chenguang Biological Technology Group Co, Ltd, Handan, 057250, China.
J Ethnopharmacol. 2022 Oct 28;297:115520. doi: 10.1016/j.jep.2022.115520. Epub 2022 Jul 3.
Marigold flavonoids, extracted from marigold (Tagetes erecta L.) inflorescence residues, have attracted significant attention with respect to antioxidant, anti-inflammatory and chelating properties. However, the toxicity of marigold flavonoids have not yet been fully investigated.
The main purpose of this study was to assess the safety of marigold flavonoids extracted from Marigold (Tagetes erecta L.) in order to provide information on its nonclinical safety. Thus, the acute oral toxicity, in vitro Ames test, sperm aberration study, bone marrow micronucleus test, subchronic oral toxicity test, and teratogenic potential were carried out in rats or mice.
For an acute oral toxicity test, SD rats and ICR mice (male and female, n = 5) orally received a single dose of 5000 mg/kg marigold flavonoids. Evaluation of marigold flavonoids genotoxic potential with a battery of tests, including an in vitro bacterial reverse mutation test using four mutant strains of Salmonella typhimurium (TA、TA、TA、TA), an sperm aberration test and an in vivo micronucleus test using bone marrow cells ICR mice that were orally administered marigold flavonoids, an subchronic oral toxicity study and teratogenic test employing male and female SD rats that were orally administered marigold flavonoids. All animals tests were completed in accordance with GB 15193 for toxicity tests.
In the acute oral toxicity test, marigold flavonoids given at the dose of 5000 mg/kg body weight for 14 days didn't produce any abnormal clinical symptoms or mortality in SD rats and ICR mice (both sex, n = 5). There was no evidence of genotoxicity of marigold flavonoids based on the results of the in vitro bacterial reverse mutation test (up to 1250 μg/plate), the sperm aberration test (up to 5000 mg/kg body weight), the in vivo micronucleus test (up to 5000 mg/kg body weight), the subchronic oral toxicity study (up to 10 g/kg feed dose) and the teratogenic test (up to 1250 mg/kg body weight).
We found that marigold flavonoids are safe with regard to acute toxicity in rats or mice as well as genotoxicity such as mutagenesis or clastogenesis under the present experimental conditions. These results might support the safety of marigold flavonoids as a potential therapeutic material for the traditional use of herbal medicines and for the further development of novel antioxidant.
从万寿菊花(Tagetes erecta L.)花序残体中提取的万寿菊花黄酮,因其具有抗氧化、抗炎和螯合特性而受到广泛关注。然而,万寿菊花黄酮的毒性尚未得到充分研究。
本研究的主要目的是评估从万寿菊(Tagetes erecta L.)中提取的万寿菊花黄酮的安全性,为其非临床安全性提供信息。因此,在大鼠或小鼠中进行了急性口服毒性试验、体外 Ames 试验、精子畸变试验、骨髓微核试验、亚慢性口服毒性试验和致畸潜力试验。
对于急性口服毒性试验,SD 大鼠和 ICR 小鼠(雌雄各 5 只)口服给予 5000mg/kg 剂量的万寿菊花黄酮。采用包括使用四个鼠伤寒沙门氏菌突变株(TA98、TA100、TA1535 和 TA1537)的体外细菌回复突变试验、精子畸变试验和 ICR 小鼠骨髓细胞体内微核试验、亚慢性口服毒性试验和致畸试验等一系列试验评价万寿菊花黄酮的遗传毒性潜力。雄性和雌性 SD 大鼠口服给予万寿菊花黄酮。所有动物试验均按照 GB 15193 毒性试验进行。
在急性口服毒性试验中,SD 大鼠和 ICR 小鼠(雌雄各 5 只)在 5000mg/kg 体重剂量下连续 14 天未出现任何异常临床症状或死亡。基于体外细菌回复突变试验(高达 1250μg/平板)、精子畸变试验(高达 5000mg/kg 体重)、体内微核试验(高达 5000mg/kg 体重)、亚慢性口服毒性试验(高达 10g/kg 饲料剂量)和致畸试验(高达 1250mg/kg 体重)的结果,万寿菊花黄酮没有表现出遗传毒性。
在本实验条件下,我们发现万寿菊花黄酮在大鼠或小鼠急性毒性以及致突变或致裂变性等遗传毒性方面是安全的。这些结果可能支持万寿菊花黄酮作为草药传统用途的潜在治疗材料和新型抗氧化剂的进一步开发的安全性。